Protocol No: ECCT/11/08/05 Date of Protocol: 15-02-2011

Study Title:

 

Evaluation of a rifapentine-containing regimen for intensive phase treatment of pulmonary tuberculosis

Study Objectives:
Laymans Summary:
Abstract of Study:

 

The goal of this Phase 2 clinical trial is to evaluate the antimicrobial activity and safety of  experimental intensive phase (first 8 weeks of treatment) tuberculosis treatment regimens in which rifapentine is substituted for rifampin.